Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas

In this page

Clinical Trial

NCT05101148 Active, Not recruiting
Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas

Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas

Phase 1
Interventional

Disease

Disease type

Other

Paediatric clinical trials

Orphan drug recognition

Yes

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

21/07/2021

Closing date

06/04/2022

Inclusion criteria :

More

Exclusion criteria :

More

Funding

private

Members involved

Others investigators

Dr Marta Morales Ballús

Representative

Spain

Anterior Segment Rare Eye Diseases (WG4), CPMS & Digital Medecine (TWG10), Genetic Diagnostics (TWG6), National Integration (TWG9), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8)
See more

ERN EYE member investigating site

HCP : Principal investigators